Hangyu Gu | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Hangyu Gu | Medicine and Dentistry | Best Researcher Award

Beijing Jishuitan Hospital | China

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Hangyu Gu embarked on his journey in medicine at the prestigious Peking University, where he earned his Bachelor’s Degree in Medicine between September 2004 and July 2010. Demonstrating a clear commitment to clinical excellence, he pursued further specialization and obtained his Medical Doctor’s Degree from the same institution by July 2012. His early academic years laid a strong foundation in medical science and surgical disciplines, setting the tone for a career deeply rooted in evidence-based practice and patient-centered care.

🏥 Professional Endeavors

Dr. Gu began his clinical practice as an intern at the No.2 Affiliated Hospital of Peking University from March 2010 to July 2011. He quickly advanced to become a resident in surgery at the same hospital, gaining invaluable experience in surgical protocols and trauma care. From August 2012 to April 2018, he served as an orthopedic fellow at the renowned Beijing Jishuitan Hospital, affiliated with Peking University’s Fourth Medical College. Since May 2018, he has been serving as an attending physician in the Department of Orthopedics and Traumatology at the same institution, where his clinical and surgical expertise continues to grow.

🔬 Contributions and Research Focus

Dr. Gu’s research interests focus primarily on orthopedic surgery, trauma recovery, and post-surgical outcomes in elderly patients. In 2022, he co-authored a study titled “Combination of Cable Cerclage and Hook Plate for the Fixation of Comminuted Fractures of Inferior Patellar Pole,” published in Orthopaedic Surgery, which reviewed the outcomes of 16 patients followed up for a year. In 2023, he contributed to groundbreaking research on femoral neck fractures, identifying how complete posterior cortex fractures increase the risk of avascular necrosis in elderly patients—published in the Chinese Medical Journal.

🏆 Accolades and Recognition

While formal awards are not listed, Dr. Gu's continuous appointment and academic contributions at one of China's top orthopedic institutions speak volumes about his professional esteem and peer recognition. His publication in internationally recognized journals reflects the impact and credibility of his research within the orthopedic community.

🌍 Impact and Influence

Dr. Gu's work significantly influences clinical decisions in orthopedic trauma management, especially for aging populations—a demographic increasingly prone to hip and knee fractures. His research contributes to improved surgical techniques and enhanced patient outcomes, guiding surgeons worldwide in managing complex cases with precision and care.

🔮 Legacy and Future Contributions

With an impressive blend of clinical experience and academic rigor, Dr. Hangyu Gu is poised to make lasting contributions to orthopedic innovation and surgical education. As he continues to publish and mentor, his influence will likely shape future best practices in fracture fixation and geriatric trauma care, advancing both national and global orthopedic standards.

Publications

📝 A Comparative Finite Element Study of Novel Design Hook Plates for Fixation of Patella Fracture

Authors: Cunxiang Ma, Jingyu Pan, Teng Zhang, Junqiang Wang, Wei Han, Hangyu Gu
Journal: Injury
Year: 2025

📝 Combination of Cable Cerclage and Hook Plate for the Fixation of Comminuted Fractures of Inferior Patellar Pole: A Review of 16 Consecutive Patients Followed Up for a Minimum of 1 Year

Authors: Hangyu Gu, Shiwen Zhu, Ting Li, Xinbao Wu
Journal: Orthopaedic Surgery
Year: 2022

📝 Complete Fracture of Posterior Cortex Increases the Risk of Avascular Necrosis After Osteosynthesis for Non-Displaced Femoral Neck Fractures in Elderly Patients

Authors: Hangyu Gu, Qianqian Wang, Minghui Yang, Xinbao Wu, Faming Tian, Shiwen Zhu
Journal: Chinese Medical Journal
Year: 2023

Kalei Hering | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Kalei Hering | Medicine and Dentistry | Best Researcher Award

Harvard Medical School | United States

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Kalei Hering’s academic journey began at the United States Military Academy at West Point, where she majored in Life Sciences with honors, following a pre-medical and nuclear engineering track. As a Barry Goldwater Scholar and Rhodes Scholar Finalist, her undergraduate years were marked by distinction and ambition. She then advanced to Harvard Medical School, where she pursued her M.D. with exceptional performance, scoring a 265 on the USMLE Step 2 CK and actively engaging in research and leadership.

🩺 Professional Endeavors

Currently a Resident Physician in Diagnostic Radiology at Walter Reed National Military Medical Center (expected 2030), Dr. Hering is integrating rigorous clinical training with a robust military medical background. She has held numerous leadership positions—from Platoon Leader to President of Harvard’s Interventional Radiology Interest Group—reflecting a rare blend of military discipline and medical acumen. Her clinical and surgical experiences at institutions like Walter Reed, MGH, and BIDMC have laid a strong foundation for a future in academic and interventional radiology.

🔬 Contributions and Research Focus

Dr. Hering’s research spans vascular and interventional radiology, pulmonary arteriovenous malformations, trauma imaging, and military health, with over 20 peer-reviewed publications. She has contributed to top-tier journals including CHEST, Spine Journal, Journal of Vascular and Interventional Radiology, and Military Medicine. As an editor for the MGH “White Book”, she has also shaped essential medical manuals for house staff. Her passion for research was recognized early through internships and fellowships, including work on Lyme disease and steroid hormone physiology.

🏅 Accolades and Recognition

A decorated scholar and athlete, Dr. Hering has earned numerous honors including:
🏆 1897 Fellowship Awardee (Top national Phi Kappa Phi applicant)
🥇 Trainee Case Competition Winner, New England Society of Interventional Radiology
🏃‍♀️ Champion in multiple marathons and ultramarathons including the Candlelight 12-Hour and Spartan Race
🎖️ Excellence in Life Science Award, Brigadier General Ramsden Award, and LTC Boyd Harris Leadership Award at West Point
📚 Recognized by the West Point Superintendent for academic, military, and physical excellence

🌍 Impact and Influence

Dr. Hering is a changemaker in both academic medicine and military health systems. Her efforts to increase access and mentorship—such as developing shadowing programs, founding wellness initiatives, and mentoring underrepresented pre-med students—demonstrate her commitment to building inclusive, high-impact medical communities. Her involvement in the Society of Interventional Radiology, Excelsior Surgical Society, and Empower Conference reflects a strategic vision for the future of healthcare delivery, particularly in military and interventional contexts.

🔮 Legacy and Future Contributions

With a rare combination of military leadership, scientific rigor, and clinical excellence, Dr. Kalei Hering is poised to leave a lasting mark on the fields of interventional radiology, medical education, and military medicine. Her pursuit of innovative techniques, policy development, and mentorship ensures that her influence will be deeply felt across clinical, academic, and operational environments for years to come. As she advances through her residency and beyond, Dr. Hering stands as a beacon of resilience, intellect, and service in modern medicine.

Publications

📄 Post-Treatment Monitoring of Pulmonary Arteriovenous Malformations: Challenges and Approaches

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: CHEST

  • Year: 2025

📄 Embolization of a Bleeding Duodenal Arteriovenous Malformation with a Conformable Embolic Material (Obsidio): Case Report

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: Journal of Clinical Interventional Radiology ISVIR

  • Year: 2025

📄 Long-Term Quality of Life and Functional Outcomes After Management of Spinal Epidural Abscess

  • Authors:  Kalei Hering, Grace X. Xiong, Andrew Nguyen, Andrew J. Schoenfeld

  • Journal:  The Spine Journal

  • Year: 2024

📄 Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

  • Authors: Kalei Hering, Miles W.A. Fisher, Michael K. Dalton, Andrew K. Simpson, Jamie Ye, Nishant Suneja, Zara Cooper, Tracey P. Koehlmoos, Andrew J. Schoenfeld

  • Journal: Journal of Bone and Joint Surgery

  • Year: 2022

 

Chaoyang Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Chaoyang Zhang | Medicine and Dentistry | Best Researcher Award

The Primasia International Eye Research Institute of The Chinese University of Hong Kong | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Zhang began his academic journey with a Bachelor's degree in Animal Science from Shihezi University in 2013. Inspired to pursue clinical science, he undertook a Ph.D. in Clinical Medicine at Tongji University, completing his doctoral studies in 2020 under the guidance of Professors Guo-Tong Xu and Jingfa Zhang. His doctoral training laid a robust foundation for translational research in ophthalmology.

💼 Professional Endeavors

Following his Ph.D., Dr. Zhang served as an Assistant Research Fellow at the Department of Ophthalmology, Shanghai General Hospital (Shanghai Jiao Tong University School of Medicine), from 2020 to 2024. In this role, he also functioned as Scientific Secretary, actively contributing to the National Clinical Research Center for Eye Diseases. Since September 2024, he has held the position of Associate Research Fellow at The Primasia International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), where he continues to push the frontiers of ophthalmic research.

🔬 Contributions and Research Focus

Dr. Zhang’s research centers on the pathogenesis and treatment of diabetic retinopathy, diabetic macular edema, and subretinal fibrosis in neovascular age-related macular degeneration. His scientific approach integrates molecular biology, pharmacology, and clinical ophthalmology.

He has authored over 10 high-impact publications as first or co-first author in Q1 journals such as Pharmacological Research, Phytomedicine, and Investigative Ophthalmology & Visual Science. His works explore:

  • Roles of Aquaporin 11 in Müller cell water transport and retinal edema
  • Anti-fibrotic effects of Luteolin via Smad2/3 and YAP pathways
  • γ-Secretase inhibition as a therapeutic target for subretinal fibrosis
  • Erythropoietin's role in maintaining the blood-retinal barrier

His current research is supported by a Youth Program Grant from the National Natural Science Foundation of China, exploring AQP11-ERS-ATF4 axis signaling in diabetic retinopathy.

 

🏅 Accolades and Recognition

Dr. Zhang holds a national patent on Aquaporin11 expression enhancement and is a named researcher on multiple national-level grant projects. His contributions have been recognized through:

  • Prestigious funding from NSFC Youth and General Programs
  • Active membership in the Shanghai Medical Association’s Visual Research Group
  • Peer reviewer roles for high-impact journals like iScience and International Immunopharmacology

🌐 Impact and Influence

Dr. Zhang is a valued member of China’s ophthalmic research community, bridging fundamental science with clinical application. His collaborations with prominent institutions and ongoing contributions to professional societies highlight his growing influence. He has served as an academic reviewer and an integral part of collaborative multi-institutional research on vision-threatening disease

🌟 Legacy and Future Contributions

Looking ahead, Dr. Chaoyang Zhang is poised to redefine therapeutic strategies for vision impairment. His interdisciplinary research, blending genetics, pharmacology, and clinical trials, positions him to make enduring contributions to global eye health. With a strong portfolio of publications, active grants, and a forward-thinking approach, Dr. Zhang represents the future of translational ophthalmology.

 

Publications

📄 Nintedanib Inhibits Neovascularization and Subretinal Fibrosis in a Laser-Induced Choroidal Neovascularization Mouse Model
Authors: Shiyue Qin, Yingying Zhu, Yinping Liu, Hai Xie, Jingfa Zhang, Chaoyang Zhang, Guoxu Xu
Journal: Biochemical and Biophysical Research Communications
Year: 2025

📄 Glucose transport, transporters and metabolism in diabetic retinopathy
Authors: Chaoyang Zhang, Gu L., Xie H., Liu Y., Huang P., Zhang J., Luo D., Zhang J.
Journal: Biochimica et Biophysica Acta - Molecular Basis of Disease
Year: 2024

📄 Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration
Authors: Dandan Liu, Jingxiao Du, Hai Xie, Haibin Tian, Lixia Lu, Chaoyang Zhang, Guo-Tong Xu, Jingfa Zhang
Journal: Journal of Neuroinflammation
Year: 2024

📄 Application and prospect of gene therapy for fundus vascular diseases (基因治疗在眼底血管性疾病中的应用和展望)
Authors: Chaoyang Zhang, Jingxiang Zhang, Jingfa Zhang
Journal: International Eye Science
Year: 2023

📄 Aquaporin 11 alleviates retinal Müller intracellular edema through water efflux in diabetic retinopathy
Authors: Chaoyang Zhang, Dong Luo, Hai Xie, Qian Yang, Dandan Liu, Liang Tang, Jian Zhang, Weijia Li, Haibin Tian, Lixia Lu, Xiaodong Sun, Guo-Tong Xu, Jingfa Zhang
Journal: Pharmacological Research
Year: 2023

Narcis Valentin Tănase | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assist. Prof. Dr. Narcis Valentin Tănase | Medicine and Dentistry | Best Researcher Award

Carol Davila University of Medicine and Pharmacy | Romania

Author Profile

Scopus

Orcid

Google Scholar

🌱 Early Academic Pursuits

Dr. Narcis Valentin Tănase began his academic journey at the “Zinca Golescu” Theoretical High School in Pitești, graduating in 1991. He then pursued his medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, graduating in 1997 as a Doctor of Medicine 🎓. His commitment to continuous learning is reflected in further postgraduate training and specialization courses both in Romania and abroad.

🩺 Professional Endeavors

Since 2008, Dr. Tănase has been serving as a Consultant in Anesthesia and Intensive Care at the "Dr. Carol Davila" Central Military Emergency University Hospital in Bucharest. He also holds a position as an Assistant Professor at the Carol Davila University of Medicine and Pharmacy in the Department of Anesthesia and Intensive Care III. His earlier career includes roles as a medical resident and specialist in the same institution, showcasing a deep-rooted commitment to intensive care medicine over more than two decades.

🔬 Contributions and Research Focus

Dr. Tănase’s scientific research revolves around anesthesia, intensive care, pain management, and perioperative medicine. He has acted as Principal Investigator in notable international studies like PAIN OUT and the European Observational Study on Chronic Post-Surgical Pain. He has co-authored and authored numerous indexed scientific publications, covering complex case studies, anesthetic techniques like TIVA-TCI, and pain modulation strategies. He has also contributed to several medical textbooks and conference proceedings .

His involvement in over 20 national and international trials, workshops, and multicenter research programs underscores a dedication to evidence-based practice and advancing critical care medicine.

🏆 Accolades and Recognition

Dr. Tănase has been decorated with some of Romania’s most prestigious medical honors for military professionals:

  • Knight of the Order of Sanitary Merit (2010) 🛡️

  • Officer of the Order of Sanitary Merit (2021) 🎖️

  • Commander of the Order of Sanitary Merit (2024) 🏅

These awards reflect not only his clinical excellence but also his service to the military medical system in Romania.

🌍 Impact and Influence

Dr. Tănase has significantly shaped the Romanian intensive care landscape. As Coordinator of Transplant Programs at the Central Military Hospital (2014–2024), he contributed to life-saving procedures and the development of transplant infrastructure. He has organized and chaired several major congresses including the 16th Congress of the Balkan Military Medical Committee. Additionally, his role as President of the Hospital’s Ethics Committee since 2023 affirms his leadership in institutional governance.

His teaching activities, including national symposiums and international workshops, position him as a leading mentor in critical care and anesthesiology .

🌟 Legacy and Future Contributions

As a passionate educator and researcher, Dr. Narcis Valentin Tănase continues to shape the future of anesthesia and intensive care in Romania and beyond. His ongoing doctoral studies, editorial contributions to indexed journals, and mentorship roles ensure a growing legacy of scientific excellence, innovation, and ethical clinical practice. His vision includes refining protocols for postoperative care, enhancing pain management techniques, and expanding international collaboration in clinical research 🚀.

Publications

📄 A Clinical Comparative Study of Schnider and Eleveld Pharmacokinetic–Pharmacodynamic Models for Propofol Target-Controlled Infusion Sedation in Drug-Induced Sleep Endoscopy
Authors: Narcis Valentin Tănase, Răzvan Hainăroșie, Lăcrămioara-Aurelia Brîndușe, Dan Corneci, Catalina Voiosu, Andreea Rusescu, Cristian Cobilinschi, Camelia Stanciu Găvan, Viorel Zainea
Journal: Biomedicines
Year: 2025

📄 Study of Two Sedative Protocols for Drug-Induced Sleep Endoscopy: Propofol versus Propofol-Remifentanil Combination, Delivered in Target-Controlled Infusion Mode
Authors: Narcis-Valentin Tănase, Răzvan Hainăroșie, Lăcrămioara-Aurelia Brîndușe, Cristian Cobilinschi, Madalina Dutu, Dan Corneci, Viorel Zainea
Journal: Medicina
Year: 2024

📄 Clinical Characteristics and Factors Associated with ICU Mortality During the First Year of the SARS-Cov-2 Pandemic in Romania: A Prospective, Cohort, Multicentre Study of 9000 Patients
Authors: Bubenek-Turconi S.I., Andrei S., Valeanu L., Stefan M.-G., Grigoras I., Copotoiu S., Bodolea C., Tomescu D., Popescu M., Filipescu D., et al.
Journal: European Journal of Anaesthesiology
Year: 2023

📄 Cervico-Thoracic Air Collections in COVID-19 Pneumonia Patients – Our Experience and Brief Review
Authors: C.E. Nistor, C.S. Gavan, D. Pantile, N.V. Tănase, A. Ciuche
Journal: Chirurgia (Romania)
Year: 2022

📄 Individualized Surgical Antibiotic Prophylaxis – Why, When, and How?
Authors: Dan Corneci, Ligia I. Torsin, Cristina R. Filimon, Narcis V. Tănase, Emanuel Moisa, Silvius I. Negoita
Journal: Romanian Journal of Military Medicine
Year: 2022

Adam Kern | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Adam Kern | Medicine and Dentistry | Best Researcher Award

University of Warmia and Mazury | Poland

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Adam Kern’s journey into medicine began with his M.D. from the Medical University in Gdańsk in 1995, followed by a Ph.D. from the Medical University of Poznań in 2005. In 2019, he achieved the title of Associate Professor from the University of Warmia and Mazury, where his academic and clinical pursuits have continued to flourish. His early dedication laid a strong foundation for his future contributions in cardiology.

🏥 Professional Endeavors

Dr. Kern currently serves as an Associate Professor in the Department of Cardiology and Internal Medicine at the University of Warmia and Mazury, and as Head of the Cardiac Catheterization Laboratory at Voivodal Specialist Hospital in Olsztyn, Poland. With a career spanning over two decades, he has held various positions from Resident to Senior Assistant and now leads invasive cardiology in both academic and clinical settings. He has overseen over 10,000 coronary angiograms and 5,000 PCIs, marking his role as one of the country’s most experienced interventional cardiologists.

🔬 Contributions and Research Focus

Dr. Kern's research focuses on interventional cardiology, coronary artery bifurcation lesions, and electrotherapy. He has led or contributed to key clinical trials including TRITON TIMI-38, TWILIGHT, POLBOS LM, and PLATO. His doctoral and habilitation work tackled critical aspects of ST-segment elevation ACS and distal left main stem coronary lesions, contributing valuable insights to clinical cardiology.

📚 Scientific Achievements

With 116 published articles, including 54 in Impact Factor journals, Dr. Kern’s academic work has a cumulative impact factor of 150.407 and H-index of 9. His work has been cited 316 times, affirming his role as a respected contributor in cardiovascular medicine. He regularly presents at national and international cardiology conferences, sharing case studies, complication management insights, and advanced techniques.

👨‍🏫 Teaching and Mentorship

Dr. Kern is a passionate educator, training medical students, junior doctors, and interventional cardiologists in pacemaker implantation, angiography, and PCI. His leadership extends to organizing annual country-wide cardiology workshops in Olsztyn and delivering over 10 lectures a year to regional consultants and general practitioners.

🏆 Accolades and Recognition

Dr. Kern’s exceptional service has earned him numerous honors, including:

  • ➤"Best of the Best" Laurel by the Marshal of Warmia and Mazury (2017)

  • ➤Individual Scientific Award from the Rector of UWM (2019)

  • ➤"Meritorious Medical Doctor of Warmia and Mazury" (2020)

  • ➤"Icon of Olsztyn Medicine" (2022)
    These accolades recognize both his scientific merit and his influence in promoting regional healthcare excellence.

🌍 Impact and Influence

As a Fellow of the European Society of Cardiology (FESC) and an active member of EHRA and EAPCI, Dr. Kern's influence reaches beyond Poland. His leadership in structuring primary PCI programs, purchasing and selecting interventional equipment, and mentoring new cardiologists has shaped the cardiology landscape in Warmia and Mazury.

🔮 Legacy and Future Contributions

Dr. Adam Kern continues to build a legacy of clinical precision, academic excellence, and community leadership. His deep involvement in research, combined with a hands-on role in saving lives through interventional procedures, ensures his future contributions will continue to elevate cardiovascular care both nationally and internationally. His leadership in teaching and innovation makes him a guiding force for future cardiologists.

Publications

📄 Kynurenine as a Predictor of Long-Term Mortality: A 10-Year Follow-Up from the KORONEF Registry
Journal: Biomedicines
Year: 2025
Authors: Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Krystyna Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, et al.

📄 Fractal Laws for Bifurcation Quantitative Coronary Angiography to Assess Left Main Bifurcation Lesions
Journal: Cardiology Research and Practice
Year: 2025 
Authors: Mattia Lunardi, Nozomi Kotoku, Carlo Briguori, Luc Maillard, Adam Kern, Franck Digne, Jacek Legutko, Maciej Lesiak, Adam Witkowski, Thierry Lefèvre, et al.

📄 Comparative Ten-Year Outcomes in Chronic and Acute Coronary Syndrome Patients Undergoing Invasive Diagnostics—Insights from the KORONEF Registry
Journal: Biomedicines
Year: 2024
Authors: Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Krystyna Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, et al.

📄 Percutaneous Coronary Interventions with Sirolimus-Eluting Alex Plus Stents in Patients with or without Diabetes: 4-Year Results
Journal: Journal of Cardiovascular Development and Disease
Year: 2024
Authors: Jacek Bil, Maciej Tyczynski, Adam Kern, Krystian Bojko, Robert J. Gil

Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Laval University | Canada

Author Profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Abdelaziz Ghanemi’s academic foundation reflects both intellectual rigor and global engagement. He graduated as the top student from the pharmacy program at Mentouri University of Constantine in Algeria. His quest for advanced scientific knowledge led him to China Pharmaceutical University, where he earned a Master of Science in Pharmacology, completing more than twice the credit requirement. His research there involved high-throughput screening for dopamine D5 receptor ligands—a project using transgenic cell lines and cutting-edge fluorescence assays. He then pursued a Ph.D. in Molecular Medicine at Laval University in Canada. His doctoral thesis was a comprehensive study of gene regulation in obesity and exercise, particularly focusing on TFF2 and SPARC, and was constructed from an impressive 27 peer-reviewed publications, marking an extraordinary achievement in biomedical research.

🧪 Professional Endeavors

Dr. Ghanemi’s professional journey spans Algeria, China, and Canada, covering a spectrum of scientific, academic, and community roles. His appointments include:

👨‍🔬 Postdoctoral Fellowships at CHU de Québec–Université Laval Research Center and LOEX Regenerative Medicine Lab, where he explored obesity, vascular calcification, and 3D bioprinting for tissue engineering.
👨‍🏫 Visiting Scholar at the University of Victoria (2024), working under Prof. Stephanie Willerth on bioprinting applications in regenerative medicine.
🔬 Research Professional at the CHUQ’s Functional Genomics and SAGE platform, applying gene expression tools to decode metabolic and ageing pathways.
🌍 Interpreter and Science Communicator, fluent in Arabic, English, French, and Chinese, enhancing cross-cultural scientific collaboration.

In addition to these, Dr. Ghanemi has participated in numerous internships, including hospital pharmacy and neurobiology labs, and taught pharmacology in China—demonstrating both practical and pedagogical expertise.

🔬 Contributions and Research Focus

Dr. Ghanemi’s research covers some of the most pressing biomedical themes of our time:

🧠 Obesity and metabolism, focusing on gene-environment interactions and exercise-induced molecular changes
💪 Regenerative medicine, especially the roles of SPARC and TFF2 in ageing, obesity, and tissue repair
🧬 Genomic and transcriptomic analysis using transgenic animal models and advanced sequencing platforms
🩺 Chronic kidney disease and mineral bone disorders, examining vitamin D pathways and Wnt/β-catenin signaling

His scholarly productivity includes over 50 scientific articles, a Google Scholar h-index of 22, and contributions to high-impact journals such as Biomedicines, Metabolites, Biology, Medicines, and Cytokine.

🏅 Accolades and Recognition

Dr. Ghanemi’s excellence has been recognized globally:

🥇 “Best Student Award” during his undergraduate pharmacy studies
🏆 Oral Presentation Award at ICOMES & AOCO 2019 in Seoul for research on SPARC and exercise
🎓 Vanier Canada Graduate Scholarship Nominee, one of Canada’s most prestigious honors
💬 “Student Seminar Award” by CHU de Québec Research Center for outstanding research communication
🏅 “I Stand With Her” Award at the Women in Medicine Summit (Chicago), honoring his advocacy for women's health
🌍 Laval University Representative at the Canadian Student Health Research Forum (2021)

These distinctions underscore both the scientific value and societal impact of his work.

🌐 Impact and Influence

Dr. Ghanemi’s influence extends beyond the laboratory. His work on exercise mimetics, bioenergetics, and gene-environment crosstalk holds implications for public health, geriatrics, and personalized medicine. As an editor for a special issue in Biomedicines (2024–2025), he is shaping academic dialogue on metabolism and tissue engineering. His editorial contributions and published opinions have influenced how we view obesity, exercise biology, and post-COVID metabolic health. His multilingual ability and international collaborations make him a bridge between cultures and scientific communities.

🔮 Legacy and Future Contributions

Dr. Ghanemi's trajectory suggests a lasting legacy in translational medicine. His integration of molecular research, clinical relevance, and public health awareness positions him to advance therapeutic development in obesity, regenerative strategies, and age-related diseases. With current projects involving SPARC’s therapeutic applications, vascular biology, and bioprinted tissues, Dr. Ghanemi is at the vanguard of modern biomedical science. His commitment to publishing, mentoring, and interdisciplinary exploration signals continued contributions to global health and scientific progress.

Publications

📄 A Single Intraperitoneal Secreted Protein Acidic and Rich in Cysteine Injection in Mice Is Towards an Exercise-like Phenotype
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Biology
Year: 2025

📄 Obesity and Bone Mineral Density Protection Paradox in Chronic Kidney Disease: Secreted Protein Acidic and Rich in Cysteine as a Piece of the Puzzle?
Authors: Abdelaziz Ghanemi, Fabrice Mac-Way
Journal: Life
Year: 2023

📄 Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2023

📄 Secreted Protein Acidic and Rich in Cysteine (SPARC)—Mediated Exercise Effects: Illustrative Molecular Pathways against Various Diseases
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Diseases
Year: 2023

📄 DNA Damage as a Mechanistic Link between Air Pollution and Obesity?
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2022

Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Yoshiya Tanaka | Medicine and Dentistry | Best Researcher Award

University of Occupational and Environmental Health | Japan

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Yoshiya Tanaka embarked on his academic journey at the University of Occupational and Environmental Health, Japan (UOEH), where he earned his MD in 1984. His thirst for knowledge and commitment to medical research led him to pursue a PhD at the Graduate School of Medical Science, UOEH, which he completed in 1988. This strong academic foundation laid the groundwork for his exceptional career in internal medicine and rheumatology.

🌟 Professional Endeavors

Prof. Tanaka’s illustrious career began with a prestigious opportunity as a Visiting Fellow in the Experimental Immunology Branch at the National Cancer Institute, NIH, USA, from 1989 to 1992. Upon returning to Japan, he rapidly ascended the academic ladder, becoming a Professor and Chairman of the First Department of Internal Medicine at UOEH in 2000. His leadership and expertise earned him the role of Dean of the Graduate School of Medical Science at UOEH in 2017, followed by his appointment as Director of the International Center at UOEH in 2022.

🔬 Contributions and Research Focus

Prof. Tanaka has dedicated his career to advancing the field of rheumatology, clinical immunology, and inflammatory diseases. His research primarily focuses on rheumatoid arthritis, systemic lupus erythematosus, and novel therapeutic approaches, including Janus kinase (JAK) inhibitors and biologic therapies. His groundbreaking work on cytokine-targeting therapies has significantly influenced treatment strategies for autoimmune diseases. As a key member of multiple scientific societies, he has contributed to the Japanese College of Rheumatology (JCR), the Japanese Society of Clinical Immunology, and the Asia Pacific League of Associations for Rheumatology (APLAR). His editorial contributions include serving as an editor or associate editor for prestigious journals such as The Lancet Rheumatology, Annals of Rheumatic Diseases, and Arthritis Research & Therapy.

🏆 Accolades and Recognition

Prof. Tanaka's contributions to rheumatology and immunology have been recognized through numerous awards. In 2003, he received the Academic Award from the Japanese Society of Bone and Mineral Research (JSBMR), followed by the President Award from the Japanese College of Rheumatology in 2008. His outstanding research was acknowledged globally when he was honored with the Congress Award from the European Alliance of Associations for Rheumatology (EULAR) in 2009. In 2023, his lifelong contributions earned him the prestigious Honorary Award from EULAR.

🔍 Impact and Influence

With over 1,067 publications in English and an impressive h-index of 117, Prof. Tanaka's research has left an indelible mark on the field of rheumatology. His total impact factor of 6,402 underscores the significance of his work in shaping clinical practices worldwide. His seminal studies, including those published in Nature, The New England Journal of Medicine, and The Lancet, have influenced treatment protocols and deepened the understanding of inflammatory and autoimmune diseases. As a mentor, he has guided numerous young researchers, fostering the next generation of scientists and clinicians in Japan and beyond. His involvement in international collaborations has further solidified his role as a global leader in rheumatology research.

🌱 Legacy and Future Contributions

Prof. Tanaka’s legacy is defined by his relentless pursuit of scientific discovery and his commitment to improving patient care. His work in cytokine-targeted therapies and JAK inhibitors has paved the way for more effective and personalized treatments for autoimmune diseases. As he continues to lead groundbreaking research and mentor future medical professionals, his impact on the field will endure for generations to come. With his ongoing roles at UOEH and leadership positions in international rheumatology organizations, Prof. Tanaka remains at the forefront of medical innovation. His future contributions promise to further revolutionize treatment paradigms and enhance the quality of life for patients worldwide.

 

Publications

  • Article: Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness
    Authors: S. Kubo, Y. Miyazaki, T. Nishino, S. Nakayamada, Y. Tanaka
    Journal: Annals of the Rheumatic Diseases
    Year: 2025

  • Article: Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Authors: N. Okamoto, T.A. Atsumi, M. Takagi, Y. Tanaka, M. Kuwana
    Journal: Modern Rheumatology
    Year: 2025

  • Article: Association of peripheral CD8+ T cell activation with disease activity and treatment resistance in systemic lupus erythematosus
    Authors: Y. Fujita, S. Nakayamada, S. Kubo, H. Tanaka, Y. Tanaka
    Journal: RMD Open
    Year: 2025

  • Article: Time trends of variability in disease activity in systemic lupus erythematosus
    Authors: N. Li, A.Y.B. Hoi, S.F. Luo, R.K. Kandane-Rathnayake, E.F. Morand
    Journal: Lupus Science and Medicine
    Year: 2025

  • Article: The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with Filgotinib
    Authors: Y. Tanaka, T.A. Atsumi, D. Aletaha, C. Watson, T. Takeuchi
    Journal: Rheumatology and Therapy
    Year: 2025

 

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024

 

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications

📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025

📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025

📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024

📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024

📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024

Dong Jiang | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dong Jiang | Medicine and Dentistry | Best Researcher Award

Peking University Third Hospital | Best Researcher Award

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Dong Jiang embarked on his academic journey in clinical medicine at Peking University, where he earned his Bachelor's degree in 2004. His passion for sports medicine led him to pursue a Master's degree in the field, which he successfully completed in 2007. Determined to further his expertise, he obtained his Doctorate in Sports Medicine from Peking University in 2009. This solid academic foundation laid the groundwork for his future contributions to orthopedic sports medicine and arthroscopic surgery.

👨‍⚕️ Professional Endeavors

Prof. Jiang's professional career has been deeply intertwined with the Peking University Third Hospital. He started as an Attending Surgeon in the Department of Sports Medicine in 2009, refining his skills in arthroscopic surgery and orthopedic sports medicine. His dedication and expertise earned him the position of Associate Surgeon-in-Chief in 2014, followed by a promotion to Associate Professor in 2015. By 2019, he had ascended to the rank of Professor, Ph.D. supervisor, and Surgeon-in-Chief. Today, as the Deputy Director of the Department of Sports Medicine at Peking University Institute of Sports Medicine, he continues to advance the field through clinical excellence and research innovations.

🔬 Contributions and Research Focus

Prof. Jiang has made significant contributions to the field of orthopedic sports medicine, particularly in knee, foot, and ankle surgeries. His clinical expertise includes arthroscopy, anterior cruciate ligament reconstruction, meniscus repair, lateral ankle ligament reconstruction, and cartilage regeneration techniques. His research focuses on:

  • Tissue regeneration using mesenchymal stem cells from different sources
  • Biomechanics and mechanical memory research on stem cells
  • Tissue-engineered meniscus regeneration in sports medicine
  • Meniscus allograft transplantation and its clinical outcomes
  • Cartilage and subchondral bone regeneration
  • 3D-printed scaffolds for orthopedic and sports medicine applications

His groundbreaking studies have resulted in more than 60 research papers, including over 40 published in SCI-indexed journals. Additionally, he has contributed to one clinical practice guideline and seven textbooks on sports medicine in China, further enriching the medical community’s knowledge in this field.

🏆 Accolades and Recognition

Prof. Jiang’s relentless pursuit of excellence has been recognized through multiple prestigious awards. He has received three national and provincial scientific and technology awards for his contributions to sports medicine. His innovative research has secured 16 major research grants, including four from the Natural Science Foundation of China and the Beijing Natural Science Foundation. Moreover, he holds an impressive portfolio of 23 national patents, demonstrating his commitment to advancing medical technology in sports medicine.

🌍 Impact and Influence

Beyond academia and clinical practice, Prof. Jiang’s work has significantly influenced the field of sports medicine. His research on tissue regeneration, biomechanics, and 3D printing has opened new possibilities for treating sports injuries. His contributions to clinical practice guidelines have helped standardize treatments, ensuring better patient outcomes. As an editor and chapter contributor to numerous textbooks, he has played a crucial role in educating the next generation of orthopedic surgeons and sports medicine specialists.

🔮 Legacy and Future Contributions

Prof. Jiang’s legacy is marked by his dedication to bridging clinical expertise with cutting-edge research. As a leader in sports medicine, he continues to push the boundaries of regenerative therapies and orthopedic innovation. His future endeavors will likely focus on enhancing minimally invasive techniques, optimizing regenerative treatments, and mentoring young researchers. With his unwavering commitment to advancing sports medicine, Prof. Jiang is set to leave an indelible mark on the field, ensuring that his work benefits athletes and patients for generations to come.

 

Publications

📄Medial Cystic Osteochondral Lesions of the Talus Exhibited Lower Sports Levels, Higher Cyst Presence Rate, and Inferior Radiological Outcomes Compared With Lateral Lesions Following Arthroscopic Bone Marrow Stimulation

  • Authors: X. Cheng, J. Li, M. Pei, C. Jiao, D. Jiang

  • Journal: Arthroscopy - Journal of Arthroscopic and Related Surgery

  • Year: 2025

📄Adipose Triglyceride Lipase Suppresses Noncanonical Inflammasome by Hydrolyzing LPS

  • Authors: W. Li, Q. Liu, Y. Qian, S. Wang, P. Xia

  • Journal: Nature Chemical Biology

  • Year: 2024

📄Comparison of Subjective and Biomechanical Outcomes Between Proprioceptive Training and Modified Broström-Gould Surgery for Chronic Ankle Instability: A Randomized Controlled Trial

  • Authors: Z. Hou, S. Ren, Y. Hu, S. Zhang, D. Jiang

  • Journal: Orthopaedic Journal of Sports Medicine

  • Year: 2024

📄The Severity of Preoperative Bone Marrow Oedema Negatively Influences Short-Term Clinical Outcomes Following Arthroscopic Bone Marrow Stimulation for Osteochondral Lesions of the Talus

  • Authors: Y. Li, X. Fan, G. Zhou, Q. Zhao, D. Jiang

  • Journal: Knee Surgery, Sports Traumatology, Arthroscopy

  • Year: 2024

📄A Novel Ultrasound Method of Evaluating Dynamic Extrusion of Lateral Meniscus in Healthy Population: Different Patterns of Dynamic Extrusion Revealed Between Lateral and Medial Meniscus

  • Authors: X. Meng, Z. Li, H. Ding, L. Dai, D. Jiang

  • Journal: Journal of Ultrasound in Medicine

  • Year: 2024